The abnormal expression of SRPX2 is a common molecular characteristic of human cancers and enhanced cell metastasis and invasion by regulating the focal adhesion kinase (FAK) signaling pathway, epithelial-mesenchymal transition (EMT), angiogenesis, and glycosylation (Figure 3). This evidence concerns the gene PTK2 and cancer.